News
5d
Zacks.com on MSNCVS Health's Caremark to Lead CalPERS' PBM Vision: What's at Stake?
Detailed price information for Unitedhealth Group Inc (UNH-N) from The Globe and Mail including charting and trades.
The contract, though sizable, is likely immaterial to CVS’ earnings. But it moves the company in a positive direction as it ...
A lawsuit filed in federal court on behalf of the University of Pennsylvania and its health system alleges that 20 years of skyrocketing prices on drugs that treat diabetes, like insulin, can be ...
More than half of large U.S. employers plan to scale back healthcare benefits next year as rising costs from weight-loss and ...
For CVS, Q2 earnings will be a critical inflection point. A miss could trigger a breakup or further decline, making the stock ...
6d
New Scientist on MSNYou don't need to take drugs like Ozempic consistently to lose weight
People who take GLP-1 drugs like Ozempic can lose weight even if they face disruptions in accessing the medications, which ...
Explore more
CVS Health has secured a major healthcare deal, winning a multi-year pharmacy benefits contract with CalPERS, outbidding rival UnitedHealth. The deal marks a significant win for CVS's Caremark unit ...
Omada Health (OMDA) is a strong buy. Backed by 29 studies, key partnerships with Cigna and CVS drive growth, credibility, and ...
NEW YORK >> More than half of large U.S. employers plan to scale back healthcare benefits next year as rising costs from ...
5d
Zacks.com on MSNCan Wegovy & Ozempic Drive Another Strong Quarter for Novo Nordisk?
Novo Nordisk NVO generates most of its revenues from the sales of its blockbuster GLP-1 injections, Ozempic for type II ...
Litigation over state power to regulate pharmacy benefit managers is far from over, even after the US Supreme Court bolstered ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results